|
Your friends partial response to Herceptin is a good indicator. She should ask her onc about the ongoing clinical trials using GW572016. This drug which is now in phase III has been fast tracked by the FDA and is designed specificly for HER2+ womenwhod had no or a partial response to Herceptin.
Warmest Regards
Joe
|